ImmuneNCIt concept

https://www.has-sante.fr/jcms/p_3488174/fr/nplate-romiplostim-thrombopenie-immunologique-primaire-pti-refractaire-aux-autres-traitements
2024
false
false
false
France
Primary Immune Thrombocytopenia
evaluation of the transparency committee
nplate
principal
Romiplostim
Immunotherapy
romiplostim
Refractory
thrombocytopenia due to immune destruction, nos
Primary Refractory
romiplostim
idiopathic thrombocytopenic purpura, nos
Other Therapy
Immune
Immunology
thrombocytopenia
purpura, thrombocytopenic, idiopathic
immunology

---
https://minerva-ebp.be/FR/Article/2363
2024
Belgium
critical appraisal or critical reading
disease
disease, nos
Illinois
Useful
tretinoin
fatty acids, Omega-3
Autologous Anti-CD19/CD22 CAR T-cells AUTO3
Immune
vitamin D
Disease or Disorder
vitamin d, nos
Interleukin
fatty acid, nos
fatty acids
immune system diseases
What Month is it
Vitamin D Measurement
Ergocalciferol
Israel

---
https://pgtmsite.files.wordpress.com/2024/01/mic_msi-h_20210329_final-1.pdf
2021
Canada
drug information
Microsatellite Instability
Treatment
Therapy Object
Treat
Biomaterial Treatment
Treatment Study
During Treatment
Mismatch Repair Protein Deficiency
GDC Treatment Frequency Terminology
Regulatory Report
Clinical Testing
Repair
AML Myeloid Sarcoma Involvement Table
microsatellite instability
albumin/globulin ratio
Device System
Mycobacterium simiae Measurement
Ratio
Intervention Model
evaluation studies as topic
No Treatment for Diabetes
Immune
evaluation report
On Treatment
neoplasms
Treatment Epoch
Tumor Tissue Origin
Clinical Evaluation
Cell Cycle Checkpoint
matched-pair analysis
symptom assessment
Drug Delivery System Category
No Spacing Errors

---
https://pgtmsite.files.wordpress.com/2024/01/re_antipd1-et-msi-h-dmmr_20210629_final.pdf
2021
Canada
drug information
Treat
During Treatment
No Treatment for Diabetes
Immune
Microsatellite Instability
Treatment
Cell Cycle Checkpoint
Biomaterial Treatment
GDC Treatment Frequency Terminology
Use
neoplasms
Mismatch Repair Protein Deficiency
Mycobacterium simiae Measurement
On Treatment
Treatment Epoch
Therapy Object
Treatment Study
Immune Checkpoint Inhibitors
AML Myeloid Sarcoma Involvement Table
Tumor Tissue Origin

---